A New Tool to Promote Patient's Engagement in Their Healthcare Process
About this study
Women diagnosed with early-stage breast cancer need to make a decision about the therapeutic treatment to undertake. Since multiple factors can influence this decision, it is necessary to develop a decision-making support tool to assist them in making this choice. Main Objective: To develop a decision-making support tool for determining the treatment to undertake for women diagnosed with early-stage breast cancer and test its effectiveness on an experimental group.
- Condition
- Breast Carcinoma, Breast Cancer Stage I, Breast Cancer Stage II
- Tested
- Healthcare professionals, Patients PDA group, Patients control group
- Sponsor
- European Institute of Oncology
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 7
- Minimum age: 18 years
- Study condition: Breast Carcinoma, Breast Cancer Stage I, Breast Cancer Stage II
- be 18 or older;
- have received/receive diagnosis of resectable breast cancer in the early stage;
- women treated or who will undergo oncological treatment for early breast cancer;
- demonstrate the absence of psychopathological features.
- be willing and able to provide written informed consent/assent for the trial
Exclusion 4
- breast cancer patients who showed physical or psychological issues, as well as cognitive impairments that prohibited their participation in this type of study;
- neurological or psychiatric disorders that may compromise the patients' ability to take part in the study.
- Distant metastases from breast cancer or locally advanced/unresectable disease
- Known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
Where
1 site, 1 recruiting
European Institute of Oncology
Milan, Italy, Italy
Contact
-
Gabriella Pravettoni
0039 02 57489731 gabriella.pravettoni@ieo.it
Potential match only. Final eligibility is determined by the study team.